Healthcare provider profile · identity verified

David Wayne Dobbs, M.D.

Family Practice · LAWRENCEBURG, IN · NPI 1770501355

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	406	111
Lisinopril	Lisinopril	320	96
Amlodipine Besylate	Amlodipine Besylate	223	61
Gabapentin	Gabapentin	211	38
Metformin Hcl	Metformin Hcl	205	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	202	38
Metoprolol Succinate	Metoprolol Succinate	184	54
Hydrochlorothiazide	Hydrochlorothiazide	174	53
Pantoprazole Sodium	Pantoprazole Sodium	173	55
Duloxetine Hcl	Duloxetine Hcl	157	31
Losartan Potassium	Losartan Potassium	157	45
Omeprazole	Omeprazole	155	41
Levothyroxine Sodium	Levothyroxine Sodium	151	42
Rosuvastatin Calcium	Rosuvastatin Calcium	143	45
Albuterol Sulfate Hfa	Albuterol Sulfate	132	34
Pravastatin Sodium	Pravastatin Sodium	132	33
Allopurinol	Allopurinol	131	37
Nifedipine Er	Nifedipine	110	32
Meloxicam	Meloxicam	101	29
Metoprolol Tartrate	Metoprolol Tartrate	96	26
Glipizide	Glipizide	90	26
Lorazepam	Lorazepam	90	20
Simvastatin	Simvastatin	90	26
Montelukast Sodium	Montelukast Sodium	78	20
Sertraline Hcl	Sertraline Hcl	77	18
Eliquis	Apixaban	76	20
Tamsulosin Hcl	Tamsulosin Hcl	70	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	16
Diazepam	Diazepam	67	12
Trazodone Hcl	Trazodone Hcl	67	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	66	13
Oxycodone Hcl	Oxycodone Hcl	65	15
Clopidogrel	Clopidogrel Bisulfate	60	20
Citalopram Hbr	Citalopram Hydrobromide	59	15
Celecoxib	Celecoxib	58	11
Alendronate Sodium	Alendronate Sodium	55	16
Atenolol	Atenolol	55	17
Potassium Chloride	Potassium Chloride	55	16
Aripiprazole	Aripiprazole	52	13
Olmesartan Medoxomil	Olmesartan Medoxomil	51	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	50	23
Zolpidem Tartrate	Zolpidem Tartrate	50	13
Fentanyl	Fentanyl	49	suppressed
Methylprednisolone	Methylprednisolone	46	34
Alprazolam	Alprazolam	45	suppressed
Morphine Sulfate Er	Morphine Sulfate	45	suppressed
Ozempic	Semaglutide	45	suppressed
Clonazepam	Clonazepam	44	suppressed
Buspirone Hcl	Buspirone Hcl	41	suppressed
Furosemide	Furosemide	41	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Fenofibrate	Fenofibrate	39	suppressed
Trulicity	Dulaglutide	39	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	13
Methocarbamol	Methocarbamol	38	12
Diclofenac Sodium	Diclofenac Sodium	37	16
Pregabalin	Pregabalin	37	suppressed
Cephalexin	Cephalexin	34	28
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Lovastatin	Lovastatin	29	suppressed
Finasteride	Finasteride	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	23
Azithromycin	Azithromycin	27	23
Carvedilol	Carvedilol	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	11
Naproxen	Naproxen	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Topiramate	Topiramate	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Promethazine Hcl	Promethazine Hcl	21	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Temazepam	Temazepam	20	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	19	suppressed
Prednisone	Prednisone	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Eszopiclone	Eszopiclone	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Mometasone Furoate	Mometasone Furoate	18	13
Ondansetron Odt	Ondansetron	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Linzess	Linaclotide	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Orphenadrine Citrate Er	Orphenadrine Citrate	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Torsemide	Torsemide	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error